675
Views
19
CrossRef citations to date
0
Altmetric
Drug Evaluation

Update on reslizumab for eosinophilic asthma

, MD (Instructor of Medicine) & , MD (Professor of Medicine)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Alicia Padilla Galo, Marina Labor, Angelica Tiotiu, Ilaria Baiardini, Nicola Scichilone & Fulvio Braido. (2018) Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives. Patient Related Outcome Measures 9, pages 267-273.
Read now
Jiayuan Jiao, Jiming Wu, Jiali Wang, Yaping Guo, Le Gao, Honggang Liang, Jian Huang & Jinhui Wang. (2018) Ma Huang Tang ameliorates bronchial asthma symptoms through the TLR9 pathway. Pharmaceutical Biology 56:1, pages 580-593.
Read now
Girolamo Pelaia, Alessandro Vatrella, Maria Teresa Busceti, Luca Gallelli, Mariaimmacolata Preianò, Nicola Lombardo, Rosa Terracciano & Rosario Maselli. (2016) Role of biologics in severe eosinophilic asthma – focus on reslizumab. Therapeutics and Clinical Risk Management 12, pages 1075-1082.
Read now
Christian Pagnoux & Matthieu Groh. (2016) Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Expert Review of Clinical Immunology 12:10, pages 1059-1067.
Read now

Articles from other publishers (15)

Eric M. Wohlford, Peter F. Huang, Jennifer R. Elhawary, Lauren A. Millette, Maria G. Contreras, Jonathan Witonsky, Cécile T.J. Holweg, Sam S. Oh, Christine Lee, Christine Merenda, Ronald L. Rabin, Richardae Araojo, Angel C.Y. Mak, Celeste S. Eng, Donglei Hu, Scott Huntsman, Michael A. LeNoir, Jose R. Rodríguez-Santana, Luisa N. Borrell & Esteban G. Burchard. (2021) Racial/ethnic differences in eligibility for asthma biologics among pediatric populations. Journal of Allergy and Clinical Immunology 148:5, pages 1324-1331.e12.
Crossref
Ratoe Suraya, Tatsuya Nagano, Masahiro Katsurada, Reina Sekiya, Kazuyuki Kobayashi & Yoshihiro Nishimura. (2021) Molecular mechanism of asthma and its novel molecular target therapeutic agent. Respiratory Investigation 59:3, pages 291-301.
Crossref
Anil Nanda & Anita N. Wasan. (2020) Asthma in Adults. Medical Clinics of North America 104:1, pages 95-108.
Crossref
James G. Krings, Mary Clare McGregor, Leonard B. Bacharier & Mario Castro. (2019) Biologics for Severe Asthma: Treatment-Specific Effects Are Important in Choosing a Specific Agent. The Journal of Allergy and Clinical Immunology: In Practice 7:5, pages 1379-1392.
Crossref
Ting Liu, Faping Wang, Geng Wang & Hui Mao. (2017) Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled trials. Frontiers of Medicine 12:3, pages 340-349.
Crossref
Pulla Reddy Boggu, Jungsuk Cho, Youngsoo Kim & Sang-Hun Jung. (2018) Identification of novel 2-benzyl-1-indanone analogs as interleukin-5 inhibitors. European Journal of Medicinal Chemistry 152, pages 65-75.
Crossref
Fa-Ping Wang, Xiao-Feng Xiong, Ting Liu, Su-Yun Li, De-Yun Cheng & Hui Mao. (2016) Anti-interleukin 5 Therapy for Eosinophilic Asthma: a Meta-analysis of Randomized Clinical Trials. Clinical Reviews in Allergy & Immunology 54:2, pages 318-330.
Crossref
Patricia C. Fulkerson & Marc E. Rothenberg. 2018. 1 34 .
Pulla Reddy Boggu, Eeda Venkateswararao, Manoj Manickam, Youngsoo Kim & Sang-Hun Jung. (2017) Discovery of novel 3-(hydroxyalkoxy)-2-alkylchromen-4-one analogs as interleukin-5 inhibitors. European Journal of Medicinal Chemistry 139, pages 290-304.
Crossref
Scott Dexter Boyd, Ramona Amy Hoh, Kari Christine Nadeau & Stephen Joseph Galli. (2017) Immune monitoring for precision medicine in allergy and asthma. Current Opinion in Immunology 48, pages 82-91.
Crossref
Roopesh Singh Gangwar, Nadine Landolina, Ludovica Arpinati & Francesca Levi-Schaffer. (2017) Mast cell and eosinophil surface receptors as targets for anti-allergic therapy. Pharmacology & Therapeutics 170, pages 37-63.
Crossref
Mahin KhatamiMahin Khatami. 2017. Inflammation, Aging and Cancer. Inflammation, Aging and Cancer 261 375 .
Girolamo Pelaia, Alessandro Vatrella & Rosario MaselliGirolamo Pelaia, Alessandro Vatrella & Rosario Maselli. 2017. Asthma: Targeted Biological Therapies. Asthma: Targeted Biological Therapies 51 66 .
Fa-Ping Wang, Ting Liu, Zhu Lan, Su-Yun Li & Hui Mao. (2016) Efficacy and Safety of Anti-Interleukin-5 Therapy in Patients with Asthma: A Systematic Review and Meta-Analysis. PLOS ONE 11:11, pages e0166833.
Crossref
Stephen Joseph Galli. (2016) Toward precision medicine and health: Opportunities and challenges in allergic diseases. Journal of Allergy and Clinical Immunology 137:5, pages 1289-1300.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.